Kedem Pharmaceuticals, Inc.(fka KDMP)

[skyisnotthelimit]

l m long more thn 100k but
you and l only wish we rnt in tht big deep sht
here!!!!

Global Health Ventures Inc. Signs Equity Purchase Agreement With Lincoln Park Capital Fund, LLC
Friday, 28 May 2010 04:16pm EDT

Global Health Ventures Inc. announced that it signed an equity purchase agreement for up to $20 million with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor. The Company has the right at its discretion to sell shares of its common stock to LPC from time to time over a 30 month period in amounts between $100,000 and $1,000,000 up to the aggregate amount of $20 million depending on certain conditions as set forth in the purchase agreement including that a registration statement related to the transaction has been declared effective by the U.S. Securities & Exchange Commission.
Global Health Ventures Inc. To Close $500,000 Private Placement
Thursday, 8 Apr 2010 09:25am EDT

Global Health Ventures Inc. announced that it has completed a non-brokered private placement using Regulations S (Reg S) Exemption from the registration statement. The Company issued 625,000 units at a price of $0.80 per unit for gross proceeds of $500,000. Each unit consists of one common share and one share purchase warrant. Each share purchase warrant is exercisable into one additional common share of the Company at a price of $1.20 per share until April 08, 2015.

Global Health Ventures Inc. To Close $4,200,000 Financing With Private Investment Fund
Thursday, 25 Mar 2010 09:25am EDT

Global Health Ventures Inc. announced that it has signed an agreement with a Chicago, Illinois based investment fund (the Investor), a private limited partnership organized in Illinois, for a convertible debenture in the principal amount of $4,200,000. The debenture, which has a maturity of 48 months unless called earlier by either party, bears interest at 6% per annum. The Investor also has been granted Warrants for 800,000 shares of the Company at a pre-determined price of $1. The Investor has been granted the right of first refusal with respect to future financings.
Global Health Ventures Inc. To Collaborate With PharmaLex of Mannhein Germany To File Clinical Dossier With European